Drug Type Small molecule drug  | 
Synonyms Ambroxol Hydrochloride and Clenbuterol Hydrochloride, 氨溴特罗  | 
Action modulators, agonists  | 
Mechanism SCNA modulators(Sodium voltage-gated channel alpha subunits modulators), β2-adrenergic receptor agonists(Beta-2 adrenergic receptor agonists)  | 
Therapeutic Areas  | 
Active Indication  | 
Inactive Indication-  | 
Originator Organization  | 
Active Organization  | 
Inactive Organization-  | 
License Organization-  | 
Drug Highest PhaseApproved  | 
First Approval Date China (17 Mar 2004),   | 
Regulation-  | 
Molecular FormulaC12H19Cl3N2O  | 
InChIKeyOPXKTCUYRHXSBK-UHFFFAOYSA-N  | 
CAS Registry21898-19-1  | 
| KEGG | Wiki | ATC | Drug Bank | 
|---|---|---|---|
| - | - | - | 
| Indication | Country/Location | Organization | Date | 
|---|---|---|---|
| Respiratory Diseases | China   | 17 Mar 2004 | 





